Literature DB >> 3140859

Familial neurofibromatosis and hypertrophic cardiomyopathy.

A P Fitzpatrick1, R W Emanuel.   

Abstract

Two siblings from a family in which neurofibromatosis was inherited as an autosomal dominant had hypertrophic cardiomyopathy and neurofibromatosis. Idiopathic hypertrophic cardiomyopathy may have occurred by chance in two first degree relatives with neurofibromatosis. An alternative explantation is that these diseases are both manifestations of a common hereditary defect of neural crest tissue. Another possibility is that abnormalities of catecholamine metabolism and nerve growth factor in neurofibromatosis can cause secondary ventricular hypertrophy with septal involvement.

Entities:  

Mesh:

Year:  1988        PMID: 3140859      PMCID: PMC1216562          DOI: 10.1136/hrt.60.3.247

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

Review 1.  Nerve growth factor (first of three parts).

Authors:  W C Mobley; A C Server; D N Ishii; R J Riopelle; E M Shooter
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

2.  Hypertrophic cardiomyopathy and hyperthyroidism: a report of three cases.

Authors:  C Symons; P J Richardson; O Feizi
Journal:  Thorax       Date:  1974-11       Impact factor: 9.139

3.  Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study.

Authors:  I Bjarnason; S Jonsson; T Hardarson
Journal:  Br Heart J       Date:  1982-02

Review 4.  Pathogenesis of hypertrophic cardiomyopathy: hypotheses and speculations.

Authors:  J K Perloff
Journal:  Am Heart J       Date:  1981-02       Impact factor: 4.749

5.  [Hypertrophic myocardiopathy and von Recklinghausen's disease].

Authors:  R N Sachs; C Buschauer-Bonnet; J L Kemeny; J Amouroux; J Lanfranchi
Journal:  Rev Med Interne       Date:  1984-06       Impact factor: 0.728

Review 6.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

7.  Hypertrophic obstructive cardiomyopathy and lentiginosis: a little known neural ectodermal syndrome.

Authors:  M G St John Sutton; A J Tajik; E R Giuliani; H Gordon; W P Su
Journal:  Am J Cardiol       Date:  1981-02       Impact factor: 2.778

8.  Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

Authors:  C Symons; F Fortune; R A Greenbaum; P Dandona
Journal:  Br Heart J       Date:  1985-11

9.  Effect of triac on the developing heart.

Authors:  E G Olsen; C Symons; C Hawkey
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

10.  Familial hypertrophic cariomyopathy and lentiginosis.

Authors:  B E Hopkins; R R Taylor; J S Robinson
Journal:  Aust N Z J Med       Date:  1975-08
View more
  5 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Hypertrophic cardiomyopathy and systemic lupus erythematosus.

Authors:  J Ara; J Vivancos; J Soler-Carrillo; J C Paré; R Cervera; J Font
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Cardiomyopathy in infancy: observations in an epidemiologic study.

Authors:  C Ferencz; C A Neill
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

4.  Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.

Authors:  Junwang Xu; Fraz A Ismat; Tao Wang; Min Min Lu; Nicole Antonucci; Jonathan A Epstein
Journal:  Circ Res       Date:  2009-07-02       Impact factor: 17.367

5.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.